本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

3.90
-0.1089-2.72%
成交量:123.77万
成交额:483.48万
市值:20.87亿
市盈率:-3.82
高:3.98
开:3.96
低:3.84
收:4.01
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:2.39
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.28
市盈率(LYR):-2.71

数据加载中...

2023/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

重要事件披露

Form 8-K - Current report
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

重要事件披露

Form 8-K - Current report
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals